💊 Bayer says Marhaba to Egypt; The HHS puts in $110-mn for Sudan ebolavirus

#190 | Lupin ties up with UnitAid for TB drugs

Hello, and welcome back to The Kable, and to a brand new week. Mondays are quiet on the news front. This Monday is no exception.

For India's Maiden Pharma, it must've been one stormy weekend after India's pharma exports council, the Pharmaceuticals Export Promotion Council of India (Pharmexcil), suspended Maiden's export license on Saturday.

Separately and unrelated, Pharmexcil is hosting a virtual meet-and-greet for Indian drug exporterslooking to tap into the market in Guatemala. We presume Maiden won't be joining the Webex.

Elsewhere in India, a pandemic is raging. That of antimicrobial resistance, with doctors saying antibiotic-resistant infections alone claim the lives of nearly 60,000 newborns each year.

The fallout of infant deaths due to Maiden's cough syrups in The Gambia is spreading across neighbouring countries. Regulators in Rwanda have started investigating the cough syrups after the WHO's alert last week.